NCT01632696View on ClinicalTrials.gov

Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors

EARLY_PHASE1TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Malignant Solid Tumor
Interventions
DRUG

I-124 PGN650 for PET/CT

I-124 PGN650 for PET/CT Day 1, Day 2 and 3.

Trial Locations (1)

63110

Washington University School of Medicine, Siteman Cancer Center, St Louis

Sponsors
All Listed Sponsors
lead

Peregrine Pharmaceuticals

INDUSTRY